Ana M. Pena-Matilla

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer).

A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer).

Journal: Future oncology (London, England)

Published: April 15, 2026

Is the era of personalized dosimetry in hepatic radioembolization coming to an end?

Is the era of personalized dosimetry in hepatic radioembolization coming to an end?

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: November 20, 2025

Radiation segmentectomy with resin microspheres for hepatocellular carcinoma: a state-of-the-art review highlighting evidence gaps and future research needs.

Radiation segmentectomy with resin microspheres for hepatocellular carcinoma: a state-of-the-art review highlighting evidence gaps and future research needs.

Journal: EJNMMI physics

Published: November 03, 2025

Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study.

Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study.

Journal: Therapeutic advances in gastroenterology

Published: June 08, 2023

Neoadjuvant combined strategy to surgery based on chemoembolization and lenvatinib in hepatocellular carcinoma.

Neoadjuvant combined strategy to surgery based on chemoembolization and lenvatinib in hepatocellular carcinoma.

Journal: Gastroenterologia y hepatologia

Published: May 09, 2021

Assessing the impact of COVID-19 on liver cancer management (CERO-19).

Assessing the impact of COVID-19 on liver cancer management (CERO-19).

Journal: JHEP reports : innovation in hepatology

Published: November 21, 2020

Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice.

Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice.

Journal: Journal of clinical pharmacy and therapeutics

Published: February 13, 2018

Downstaging of bilobar hepatocellular carcinoma after radioembolization with 90Y microspheres as a bridge to liver transplantation.

Downstaging of bilobar hepatocellular carcinoma after radioembolization with 90Y microspheres as a bridge to liver transplantation.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: September 27, 2016

Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies.

Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies.

Journal: Transplantation proceedings

Published: November 26, 2014

Cardiovascular toxicity and sorafenib: a case report.

Cardiovascular toxicity and sorafenib: a case report.

Journal: American journal of therapeutics

Published: May 17, 2013

Antiangiogenic drugs and cardiogenic shock: a case report.

Antiangiogenic drugs and cardiogenic shock: a case report.

Journal: American journal of therapeutics

Published: January 25, 2013

Biliopleural fistula after radiofrecuency ablation of hepatocellular carcinoma.

Biliopleural fistula after radiofrecuency ablation of hepatocellular carcinoma.

Journal: Revista espanola de enfermedades digestivas

Published: September 29, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026